SEQ (n = 70) | CON (n = 52) | |||||||
---|---|---|---|---|---|---|---|---|
After 2 cycles chemotherapy | After chemotherapy and radiotherapy | After chemotherapy and radiotherapy | ||||||
Primary (%) | Nodes (%) | Primary (%) | Nodes (%) | Primary (%) | p2) | Nodes (%) | p2) | |
Evaluable | 93 (65/70) | 93 (65/70) | 89 (62/70) | 86 (60/70) | 98 (51/52) | 0.02 | 98 (51/52) | 0.00 |
Complete response 1) (CR) | 11 | 7 | 41 | 33 | 46 | n.s. | 58 | n.s. |
Partial remission 1) (PR) | 51 | 51 | 26 | 33 | 44 | n.s. | 37 | n.s. |
CR and PR | 63 | 59 | 67 | 66 | 90 | n.s. | 94 | n.s. |
NC, Progressive disease | 30 | 33 | 21 | 20 | 8 | n.s. | 4 | n.s. |